MIRM Stock Price Prediction 2026
Mirum Pharmaceuticals, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.4657)
Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
Options Analysis: 1-Year Target Strategy
Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).
The $90 call expiring Dec 18, 2026 costs $6.48. If MIRM reaches the Wall Street analyst target of $98.60, this option would be profitable with a 32.7% return.
Note: Options involve significant risk. Only invest what you can afford to lose.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $103.75 | +0.5% |
| 90 Days | $104.89 | +1.6% |
| 6 Months | $106.56 | +3.2% |
| 1 Year | $109.90 | +6.5% |
More MIRM Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results
Technical Indicators
Key Fundamentals
Options Activity
Recommendation: Moderate unusual activity. Monitor closely.